APA (7th ed.) Citation

PA, N., JM, D., JP, D., NB, P., JL, B., BC, H., . . . MK, R. (2022). IMM-BCP-01, a patient-derived anti-SARS-CoV-2 antibody cocktail, is active across variants of concern including Omicron BA.1 and BA.2. Science immunology, 7(75), eabl9943. https://doi.org/10.1126/sciimmunol.abl9943

Chicago Style (17th ed.) Citation

PA, Nikitin, et al. "IMM-BCP-01, a Patient-derived Anti-SARS-CoV-2 Antibody Cocktail, Is Active Across Variants of Concern Including Omicron BA.1 and BA.2." Science Immunology 7, no. 75 (2022): eabl9943. https://doi.org/10.1126/sciimmunol.abl9943.

MLA (9th ed.) Citation

PA, Nikitin, et al. "IMM-BCP-01, a Patient-derived Anti-SARS-CoV-2 Antibody Cocktail, Is Active Across Variants of Concern Including Omicron BA.1 and BA.2." Science Immunology, vol. 7, no. 75, 2022, p. eabl9943, https://doi.org/10.1126/sciimmunol.abl9943.